Perpetua Resources Corp (PPTA)vsVersamet Royalties Corporation Common Stock (VMET)
PPTA
Perpetua Resources Corp
$21.33
-9.54%
BASIC MATERIALS · Cap: $2.64B
VMET
Versamet Royalties Corporation Common Stock
$11.82
-5.39%
BASIC MATERIALS · Cap: $1.26B
Smart Verdict
WallStSmart Research — data-driven comparison
VMET leads profitability with a 58.4% profit margin vs 0.0%. VMET earns a higher WallStSmart Score of 58/100 (C).
PPTA
Avoid27
out of 100
Grade: F
VMET
Buy58
out of 100
Grade: C
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Keeps 58 of every $100 in revenue as profit
Strong operational efficiency at 90.6%
Revenue surging 594.0% year-over-year
Earnings expanding 573.0% YoY
Conservative balance sheet, low leverage
Areas to Watch
0.0% revenue growth
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Premium valuation, high expectations priced in
Smaller company, higher risk/reward
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : PPTA
The strongest argument for PPTA centers on Debt/Equity, Altman Z-Score.
Bull Case : VMET
The strongest argument for VMET centers on Profit Margin, Operating Margin, Revenue Growth. Profitability is solid with margins at 58.4% and operating margin at 90.6%. Revenue growth of 594.0% demonstrates continued momentum.
Bear Case : PPTA
The primary concerns for PPTA are Revenue Growth, EPS Growth, Profit Margin.
Bear Case : VMET
The primary concerns for VMET are P/E Ratio, Market Cap, Altman Z-Score.
Key Dynamics to Monitor
PPTA profiles as a value stock while VMET is a growth play — different risk/reward profiles.
VMET is growing revenue faster at 594.0% — sustainability is the question.
VMET generates stronger free cash flow (13M), providing more financial flexibility.
Monitor OTHER PRECIOUS METALS & MINING industry trends, competitive dynamics, and regulatory changes.
Bottom Line
VMET scores higher overall (58/100 vs 27/100), backed by strong 58.4% margins and 594.0% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Perpetua Resources Corp
BASIC MATERIALS · OTHER PRECIOUS METALS & MINING · USA
Perpetua Resources Corp. The company is headquartered in Boise, Idaho.
Visit Website →Versamet Royalties Corporation Common Stock
BASIC MATERIALS · OTHER PRECIOUS METALS & MINING · USA
Viamet Pharmaceuticals Corp (VMET) is a biopharmaceutical company focused on developing cutting-edge therapeutics for serious diseases, leveraging its proprietary metalloenzyme-based technology platform. The company is committed to addressing significant unmet medical needs in fungal infections and oncology, positioning itself as a leader in therapeutic innovation. With a diverse pipeline bolstered by strategic collaborations and a strong intellectual property portfolio, Viamet is well-prepared to advance its clinical initiatives and enhance shareholder value, aiming to redefine treatment approaches in its specialized therapeutic areas.
Compare with Other OTHER PRECIOUS METALS & MINING Stocks
Want to dig deeper into these stocks?